The Chicago Entrepreneur

[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-light"]
Menu
Top Stories

Bristol-Myers Squibb stock jumps on schizophrenia drug approval

Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.

Previous post Chinese stocks could surge higher as investors get ‘FOMO,’ Goldman Sachs says
Next post ‘I am beyond hurt’: If my husband and his son die, his house will go to his daughter-in-law. Is this nuts?

More Stories